Podcasts about mckesson

In this episode of Independent Insights, host Suzanne Feeney sits down with Josh Babb, Senior Director of Government Relations at McKesson, to unpack H.R. 3164, the Ensuring Community Access to Pharmacist Services Act (ECAPS). This bipartisan bill could be a game-changer for independent pharmacies, finally allowing Medicare Part B reimbursement for pharmacist-provided services in states where they're already authorized to deliver care. If you're an independent pharmacist, this episode is a must-listen. You'll hear real stories, understand the legislative landscape, and walk away with clear calls to action, from contacting your legislators to preparing your pharmacy for expanded services. ECAPS isn't just about policy, it's about people, access, and the future of pharmacy.HostSuzanne Feeney, PharmDSr. Director, Pharmacy SolutionsMcKesson / Health MartGuestsJosh BabbSenior Director, Government RelationsMcKessonResourcesHealth Mart University (HMU) for: Helpful CE courses and more on advocacyHealth Mart pharmacists to claim their CE credit for weekly GameChangers episodesAction Items for Listeners:Know Your LegislatorsCheck if your representatives are co-sponsors of H.R. 3164:Find Your Representative & Bill Status Contact Your LegislatorsCall or email your representative.Share personal stories of patient impact and care gaps.Ask for their support or thank them if they're already co-sponsors.Subscribe to Advocacy UpdatesStay informed and get involved through Health Mart's advocacy portal:Health Mart Advocacy Portal Prepare Your PharmacyStart offering eligible services (flue, strep, RSV, COVID-19).Explore billing options (commercial insurance, cash).Get operationally ready for Medicare reimbursement.Host a Legislator VisitInterested in hosting a member of Congress in your pharmacy?Listen to Episode 17: From Aisles to Action: Welcoming Legislators into Your Pharmacy.Reach out to McKesson or Health Mart to get connected.The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

About Lori Logan:Lori Logan is the president and CEO of NASCO, where she leads with a vision to merge innovation with a strong foundation in healthcare. Based in Englewood, Colorado, she brings over two decades of leadership across healthcare's payer, provider, and technology sectors. Known for her curiosity, analytical mindset, and collaborative leadership, Lori has consistently driven growth, transformation, and measurable impact. Her career includes leading multimillion-dollar projects, overseeing teams of hundreds, and managing large-scale integrations and mergers, and acquisitions (M&A) initiatives. Previously, she held senior roles at athenahealth, Geneia, Paladina Health, TriZetto, UnitedHealthcare, Cigna, and McKesson—where she launched groundbreaking products and strategies that improved care coordination and operational efficiency. Recognized for her strategic acumen and results-driven approach, Lori has earned industry accolades, including the TriZetto CEO Pinnacle Award and the Thomson Reuters Healthcare Advantage Award. Her mission remains clear: to reimagine healthcare and create healthier outcomes and lives.Things You'll Learn:Legacy infrastructure hinders scalability; health plans require a modern administrative “chassis” to package benefits, administer payments, and operationalize innovation. This goes well beyond traditional claims systems.Analytics must merge claims, clinical, and engagement data with medical economics precision. Insights then have to reach providers and advocates so care is both effective and reimbursable.A significant amount of value now resides outside of claims in disease management, digital tools, and condition management programs. Members need clear navigation and transparency on what they have, where to go, and what it costs.Provider enablement is essential for value-based care. Success depends on aligned incentives, shared operations, coaching, and trust between plans and providers.Strategic investments should prioritize scalable administration, robust operations, and data pipelines. These foundations let plans attribute value, manage risk, and drive affordability at scale.Resources:Connect with and follow Lori Logan on LinkedIn.Follow NASCO on LinkedIn and explore their website.

In this episode of The Dish on Health IT, host Tony Schueth, CEO of Point-of-Care Partners (POCP), is joined by colleagues Brian Dwyer, POCP's Business Strategy Lead, and Seth Joseph, Managing Director at Summit Health Advisors, to unpack their takeaways from the HLTH25 conference in Las Vegas. Together, they reflect on the energy of the event, the conversations shaping the future of health IT, and interviews recorded live from Podcast Row.The trio kicks off by comparing notes on how HLTH has evolved from a flashy innovation show to something more grounded, a space where serious conversations about interoperability, investment, and operational impact are starting to take hold. Seth notes the event's “coming-of-age” moment, where hype gave way to maturity. Brian agrees, adding that the buzz of startups pitching and investors circling was balanced by a sense of realism about implementation and outcomes.AI dominated every conversation, but with a more pragmatic tone than in years past. The hosts discuss how AI is shifting from novelty to necessity, moving from “AI for AI's sake” to purpose-driven use cases. Interview clips from leaders like Taha Kass-Hout with GE Healthcare spotlight “agentic AI,” where autonomous systems could act as trusted colleagues in care delivery, even participating in tumor board decisions to help extend expertise to rural or underserved regions. The group connects this to the ongoing challenge of ensuring data quality and interoperability as the foundation for any AI success story.Laurie McGraw of Transcarent and Kyle Kiser of Arrive Health bring different but complementary perspectives. Laurie underscores AI's potential to bend the cost curve only if applied safely and effectively, while Kyle highlights the growing complexity of affordability and the need for intelligent systems to help patients and providers navigate fragmented benefits and prescription pricing. Seth and Brian note that the shift toward patient empowerment, fueled by AI and transparency, could signal a broader cultural change in healthcare where consumers wield more influence.The discussion expands into value-based care with insights from McKesson's John Beardsley, who questions whether the industry has truly cracked the code after two decades of running at value-based care and interoperability. John also raises an important tension: small innovators are doing exciting things with AI, but scaling those solutions across full workflows remains the real test. The hosts debate whether new payment models, potentially powered by AI-driven insights, could finally make value-based care viable.Policy and regulation also take center stage as Christopher Chen, MD, MBA, Chief Medical Officer at the Washington State Health Care Authority, shares how state and federal efforts are aligning to accelerate interoperability, reduce provider burden, and modernize prior authorization processes under CMS-0057. The hosts reflect on the importance of federal leadership to align incentives across payers, providers, and technology vendors, echoing lessons learned from the early days of ePrescribing.Other memorable interview moments include John Beardsley's commentary on the CMS Interoperability and Patient App Pledges and how better understanding how NCPDP and FHIR standards bridge pharmacy and clinical data silos could help move the needle. Brian and Seth build on that theme, envisioning a future where agentic AI and patient-facing apps work together to drive true engagement and accountability for health outcomes.In the final stretch, the hosts revisit recurring topics such as physician burnout, administrative burden, and structured data chaos, tying them back to the industry's broader need for smarter implementation and aligned incentives. From Christopher Chen's relaying an anecdote about seeing structured data turned into unreadable images that are faxed in to Arrive Health's use of AI to prevent unnecessary transactions, the episode surfaces a consistent theme: technology alone won't fix healthcare, but when paired with aligned incentives, collaboration, and business transformation, it can finally make measurable progress.The episode closes with optimism. Tony, Brian, and Seth agree that while the system is strained, it's also full of momentum, from maturing AI applications to government action and renewed industry alignment. As Tony puts it, “There's a lot to be hopeful about and a lot of work left to do.”Listen to the full episode to hear interviews from the HLTH25 floor, including thought leaders discussing interoperability, agentic AI, and the real-world changes needed to make healthcare innovation stick.Share The Dish on Health IT from Spotify, Apple Podcasts, or Healthcare NOW Radio, Watch extended clips on the POCP YouTube channel

Miguel Méndez, Analista independiente, comenta su visión sobre un mercado, que cerraba el día de ayer con una venta global de chips, que ha volatilizado 500.000 millones de dólares de capitalización del mercado, ante el aumento del temor por las altas valoraciones de los grandes beneficiados por la IA. ¿Cómo ve Miguel Méndez este selloff? “Es una corrección sana, necesaria, en unas bolsas que esperan resultados empresariales. Comienza a haber rotación de capital de la tecnología a otros sectores. No veo pánico por ningún lado”. En cuanto a valores concretos, el experto financiero destaca varios, que el mismo denomina como “valor caviar”. “Los valores caviar son los que nos han demostrado que históricamente tiene una tendencia alcista muy potente, con buenos resultados, buenos ratios a nivel fundamental” explica. Cencora, Mckesson, Curtiss Wright o Motorola, son algunos de los valores que el analista destaca dentro de esta categoría. “Son valores que puedo tener en la cartera independientemente de que tenga tendencias al alza o a la baja” puntualiza .

It's the Live, Laugh, Larceny Halloween special, and we're celebrating spooky season by getting down and dirty — deep in the bowels of October. This week, Trevin faces a full-blown Halloween dilemma after realizing spiders are the only creature he likes less when they have a big butt. Because, really — anything that plump and poisonous can't be trusted. Meanwhile, Amanda's questioning her life choices after watching the Is It Cake? Halloween special and realizing that hobbyists are somehow better at everything than she is. Our game this week is a frightful All Hallow's Eve edition of This or That, where Amanda forces Trevin to choose between the true terrors of October: slasher films or psychological horror? Cute or scary costumes? Carve or paint your pumpkins? Foggy nights or full moons? Scream franchise or Halloween classics? We're tackling every haunted dilemma that defines the season. For storytime, Amanda shares the eerie tale of Shannon Dennis and Tina Jamarillo of Barstow, California — two women who let the Halloween spirit possess them a little too much. After police receive reports of a dead body in the desert, these grown adults might just end up looking like real dummies. Trevin's story opens with a nomination for the scariest Halloween costume ever: a suit. In a chillingly relatable tale of corporate America, capitalism, and existential dread, meet Bo Whitener, a Georgia man working for McKesson's pharmaceutical distribution center. When a massive CEO pension check lands in the wrong hands, Bo decides to dress up as the big boss himself for the company Halloween party — a move that might earn him a police call, a suspension, or a long interrogation by a middle manager. Beyond the usual Halloween tropes, today's episode ties together Spirit Halloween, candy corn, and — most importantly — bowels. Put on your waterproof boots and light your jack-o'-lanterns, because this true petty crime and comedy podcast special dives deep — uncomfortably deep — into the bowels of spooky season. Join our Facebook Group: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/groups/livelaughlarcenydoomedcrew⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ For ad-free episodes and lots of other bonus content, join our Patreon! ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.patreon.com/LiveLaughLarceny⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Check out our website: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Follow us on Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Follow us on Facebook: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Follow us on TikTok: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ If you have a crime you'd like to hear on our show OR have a personal petty story, email us at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠livelaughlarceny@gmail.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ or send us a DM on any of our socials! Learn more about your ad choices. Visit podcastchoices.com/adchoices

HLI Partners co-founders Joe Hills and Josh Lipoff share how they built a boutique CRE firm, Orlando industrial/office trends, and strategies to win deals.The Crexi Podcast connects CRE professionals with industry insights built for smart decision-making. In each episode, we explore the latest trends, innovations and opportunities shaping commercial real estate, because we believe knowledge should move at the speed of ambition and every conversation should empower professionals to act with greater clarity and confidence.  In this episode of The Crexi Podcast, Shanti Ryle sits with Joe Hills and Josh Lipoff to discuss their transitions from major firms to launching their own company, competitive strategies, and the intricacies of the Central Florida market. Hills and Lipoff share insights into their career paths, the importance of mentorship, and the creative solutions they employ to meet tenant needs. They also highlight market trends, investment strategies, and the challenges and opportunities in Orlando's evolving CRE landscape.Meet Joe Hills and Josh Lipoff: Founders of HLI PartnersCareer Beginnings in Commercial Real EstateEarly Challenges and MentorshipForming a Strong PartnershipLaunching HLI PartnersStrategies for Success in CRENavigating Market ChallengesCurrent Trends in Central Florida's Industrial MarketSpecialty Tenants and Market DynamicsImpact of COVID-19 on Home BuildingShifts in Industrial Space DemandBuild-to-Suit and Infill PricingMacro Factors Influencing Orlando's MarketOpportunities and Risks in Orlando's MarketRapid Fire Questions and AdviceFinal Insights and Parting Words About Joe Hills:Over the course of his career, Joe Hills has been involved in over 475 deals, closing more than 1 billion dollars in transaction volume. In 2020, Joe played a key role in the new location of a 119,684 s.f. building for Paradise Grilling System. Thereafter in 2021, Joe assisted in the building of an additional 200,000 s.f. warehouse space for Signature Brands as well as the renewal of Samsung's current lease for their 550,000 s.f. space. With an extensive track record in the industrial sector, Joe has developed a strategic orientation towards areas of manufacturing. In the span of his 15-year career in commercial real estate, Joe has successfully leased and sold more than twenty-five million square feet of space with transactions totaling more than $1 billion. About Josh Lipoff:Josh Lipoff brings over 20 years of corporate business development and has successfully negotiated several million square feet of Central Florida's Industrial team transactions. Prior to joining HLI Partners, Josh spent 12 years with JLL's Industrial team in Orlando. During his career, Josh specialized in Tenant Representation, build-to-suit and site selection, financial analysis, and lease and contract evaluation. National clients served over the years have included: Brookfield Properties, Stonemont, McKesson, Ocean Spray, Walgreens, Mattress Firm, Sysco, Freeman, Iron Mountain, United Stationers, and Kellogg's. For show notes, past guests, and more CRE content, please check out Crexi's blog.Looking to stay ahead in commercial real estate? Visit Crexi to explore properties, analyze markets, and connect with opportunities nationwide. Follow Crexi:https://www.crexi.com/​ https://www.crexi.com/instagram​ https://www.crexi.com/facebook​ https://www.crexi.com/twitter​ https://www.crexi.com/linkedin​ https://www.youtube.com/crexi

Investor Nancy Brown joins us at Aspen Ideas Health to share her blueprint for impactful investments. Identify public health breakthroughs that deliver measurable cost and quality improvements — then show how they can thrive in the marketplace. You don't have to look far to see this playbook in action. One of the year's biggest health exits, Omada Health, is a digital version of the CDC's Diabetes Prevention Program. At Oak HC/FT, Nancy has partnered with entrepreneurs who are redefining how America stays healthy — and she's eager to see more people with public health roots take the leap into building impactful companies.Please note: this conversation happened before HR1 was passed, so big Medicaid cuts were a threat but not yet a reality when we spoke.In this episode, we discuss:Lessons from Todd Park in the early days of athenahealthHow to turn good ideas into great businessesNancy's advice in an era of policy disruption: keep on building and proving valueThe lesson Kaiser Permanente is still teaching usNancy reminds us that in reality, even a brilliant idea needs to have ROI built in:“We look for entrepreneurs, for innovators, who have really defined a way in which to find a cohort of patients, it could be pregnant Medicaid moms... And they have identified if they apply a certain clinical process consistently to that population, they will get a consistently good outcome, quality outcome, and they can do it in a sustainable [way] at a sustainable price.”Relevant LinksRead Oak HC/FT's AI Investment PolicyExplore businesses Nancy mentioned from Oak HC/FT's investment portfolio:Maven ClinicOshi Health About Our GuestNancy Brown is a General Partner at Oak HC/FT, a leading venture and growth equity firm investing in transformative healthcare and fintech companies. Since joining Oak HC/FT at its inception in 2014, Ms. Brown has focused on identifying and supporting technology-enabled healthcare services that deliver measurable clinical and financial impact. She focuses on growth equity and early-stage venture investments in healthcare, serving on the boards of innovative companies such as Firefly Health, Groups Recover Together, InterWell Health, Maven Clinic, Oshi Health, Regard, Unite Us, and Wayspring. Her portfolio also includes Noom, TurningPoint Healthcare Solutions, Limeade (ASX: LME), OncoHealth, and OODA Health.Ms. Brown brings over three decades of operational and leadership experience to her investment role. Prior to Oak HC/FT, she was Vice President of Strategy and Business Development at McKesson Technology Solutions and Chief Growth Officer at MedVentive (acquired by McKesson in 2012). Previously, she served as Senior Vice President of Clinical Services and Corporate Development at athenahealth, and earlier held senior roles at McKesson and Harvard Community Health Plan. She also co-founded Abaton.com, one of the first web-based clinical solution companies, which was later acquired by McKesson.A graduate of the University of New Hampshire (B.S. in Zoology) and Northeastern University (MBA), Ms. Brown is an active mentor and advisor. She serves on Northeastern's D'Amore‑McKim School of Business Dean's Executive Council and is involved in the Roux Institute's Future of Healthcare Founder Residency program.

Under the Inflation Reduction Act (IRA), government-negotiated drug prices for high Medicare spend drugs will take effect on January 1, 2026. Pharmacies must enroll with the CMS Medicare Transaction Facilitator (MTF) to receive manufacturer refunds when the acquisition cost exceeds the Maximum Fair Price (MFP). Without enrollment, they may be excluded from the program.In this episode, we break down the critical steps pharmacies must take to enroll in the CMS MTF ahead of January 1, 2026. With manufacturer refunds hinging on proper enrollment, we explore the six-part form, key financial selections, and the role of third-party entities. We also spotlight the urgency of completing the enrollment by November 15, 2025, to avoid delays in reimbursement, for those wishing to participate in MTF. HostSuzanne Feeney, PharmDVP, Pharmacy Retail OperationsMcKesson / Health MartGuestsEmily FlaugherVice President and General Manager of Payer SolutionsMcKesson / Health Mart AtlasResources Pharmacy Toolkit on Medicare Transaction Facilitator AvailableCMS has released a pharmacy toolkit on the Medicare Transaction Facilitator (MTF) as part of the Medicare Drug Price Negotiation Program (MDPNP). The toolkit provides important information and step-by-step instructions for enrolling your pharmacy in the MTF Data Module. Additional pharmacy and dispensing entity resources are available here. As a reminder, implementation of the MDPNP will begin on January 1, 2026; pharmacies will still be able to enroll after this date.References Helpful CMS.gov Resources: Pharmacy and Dispensing Entity Resources | CMSSelected Drugs and Negotiated Prices | CMSThe views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

On "This Week in Pharmacy" for September 26th, we're talking about Trust in Healthcare, World Pharmacists Day, and Cell & Gene Therapy. Today's co-host is Dr. Melissa Smith, PharmD CPH with Florida PGx Consulting LLC. https://www.floridapgxconsulting.com/  First, #TWIRx News - the FDA approves Inluriyo imlunestrant on 9/25/2025 which is to treat estrogen receptor-positive, human epidermal growth factor receptor 2-negative, estrogen receptor-1-mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy. (https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2025)  Second, Nested-Knowledge - is going to revolutionize information access and leverage. This is a powerful tool with evidence synthesis tools for medical researchers. This will help accelerate, collaborate, automate and share the latest and personalized treatment plans. (https://nested-knowledge.com/) Next, announcing "Evidence based Podcasting", the new standard in audio learning for Providers and next level in podcast Continuing Medical Education (CME). (https://pharmacypodcast.com/2025/09/26/evidence-based-podcasting-and-the-future-of-medical-education/ ) Shout out to Nick Calla with Orsini, a leader in rare disease pharmacy solutions, has been chosen by Crinetics Pharmaceuticals, Inc., as a specialty pharmacy partner for PALSONIFY™ (paltusotine), a nonpeptide, selectively-targeted somatostatin receptor type 2 nonpeptide (SST2) agonist. (https://www.wvnews.com/news/around_the_web/partners/pr_newswire/subject/licensing_marketing_agreements/orsini-selected-as-specialty-pharmacy-partner-for-crinetics-palsonify-paltusotine/article_9b42bfe7-69a6-58be-98ff-5e2245145415.html) Today we have two guest Pharmacists to dig into the "Trust in Healthcare" theme of today's #TWIRx -- the godfather of Functional Pharmacy Robert Kress RPh., and Dr. Lauren Castle, PharmD, MS, AFMC - Founder & CEO of Functional Medicine Pharmacists Alliance. Who do you trust? What information is trustworthy and why?  Our special feature is updates on 'Cell & Gene Therapy' with McKesson's Head of Cell Gene Advanced Therapies, Joe DePinto at InspiroGene!  (https://inspirogene.com/)  Today's TWIRx is sponsored by 'Sykes & Company' the Pharmacy Accounting Jedi Masters and Independent Pharmacy Cooperative (IPC) and how they're revolutionzing digital health and new revenues with the iCare+ System!    Trust Matters, Cell and Gene, & World Pharmacists Day | TWIRx

In the tenth episode of season 4, special host Dr. Cara English, Chief Executive Officer (CEO) and Chief Academic Officer (CAO) of Cummings Graduate Institute for Behavioral Health Studies (CGI), is joined by Dr. Heather Jelonek, CGI Doctor of Behavioral Health (DBH) graduate and Regional Director at McKesson, to unpack the growing impact of insurance claim denials on patient care. They discuss the challenges providers face, the shift toward value-based care, and how DBHs are uniquely prepared to bridge payer-provider gaps while keeping patients at the center of healthcare. Tune in to learn how integrated care leaders are reshaping the future of reimbursement and access.About the Host:Dr. Cara English, DBH is the Chief Executive Officer and Chief Academic Officer of Cummings Graduate Institute for Behavioral Health Studies (CGI) and Founder of Terra's Tribe, a maternal mental health advocacy organization in Phoenix, Arizona. Dr. English spearheaded a perinatal behavioral health integration project at Willow Birth Center from 2016 to 2020 that received international acclaim through the publication of outcomes in the International Journal of Integrated Care. Dr. English served as Vice-President of the Postpartum Support International – Arizona Chapter Founding Board of Directors and co-chaired the Education and Legislative Advocacy Committees. She currently serves on the Maternal Mortality Review Program and the Maternal Health Taskforce for the State of Arizona. She served as one of three Arizonan 2020 Mom Nonprofit Policy Fellows in 2021. For her work to establish Cummings Graduate Institute for Behavioral Health Studies, Cara was awarded the Psyche Award from the Nicholas & Dorothy Cummings Foundation in 2018 and is more recently the recipient of the 2022 Sierra Tucson Compassion Recognition for her work to improve perinatal mental health integration in Arizona.About the Guests:Dr. Heather Jelonek, DBH, LAC, was born and raised in the greater Chicagoland area. She completed her Bachelor's Degree in Biology at the University of Illinois – Chicago before beginning her healthcare career at First Health Group Corp., where her passion for integrating healthcare began. As she rose within the ranks of the health insurance industry, she earned her Master Degree in Clinical Psychology at Benedictine University in Lisle Illinois. Heather holds professional licenses in the States of Illinois and Arizona as a Counselor specializing in childhood and adolescent behavioral health. Throughout her career, Dr. Jelonek struggled with closing the mental health gap with the healthcare industry and viewed this obstacle as the primary threat to the spiraling costs of healthcare. Her current role as Managing Director of Bright Health Care of Arizona created new opportunities to improve healthcare integration, improve outcomes and reduce costs from a trauma informed approach. During her studies at Cummings Graduate Institute, she was introduced to the ground breaking CDC/Kaiser Adverse Childhood Experiences study and the connection between the long-term medical costs associated and unaddressed childhood trauma. Dr. Jelonek currently resides in Phoenix, Arizona with her two furkids, Briony an English mastiff and Otto a blue heeler mix. She spends her free time hiking, gardening and challenging beliefs that mental health is different than medical health.

Ever wondered what it's really like to invite and host a legislator at your Pharmacy?In this episode of Independent Insights, we sit down with Shannon Tesini, a Certified Pharmacy Technician and passionate pharmacy advocate, to demystify the process of preparing for a legislative visit. Whether you're a technician, pharmacist, or pharmacy owner, Shannon shares what it takes to confidently represent your profession and your patients at the policy level.You'll learn:What to expect before, during, and after a legislative meetingHow to prepare your message and make it personal and powerfulTips for staying calm, clear, and confident—even if it's your first timeWhy advocacy isn't just for pharmacists—and how technicians can lead the chargeIf you've ever thought, “I care, but I don't know where to start,” this episode is your roadmap to becoming a pharmacy advocate who makes a difference.HostSuzanne Feeney, PharmDVP, Pharmacy Retail OperationsMcKesson, Health MartGuestsShannon Tesini, CPhT Pharmacy TechnicianMcNabb PharmacyResourcesTune into Episode 16: Creating Pharmacy's Future where APhA President and Health Mart pharmacy owner Randy McDonough joins McKesson Health Mart's Chief Pharmacist Nancy Lyons for a candid conversation about the urgent changes needed in pharmacy—and the bold vision that can lead us forward.Health Mart Pharmacies can access Health Mart University (HMU) for:  Helpful CE courses and more on pharmacy advocacyHealth Mart pharmacists to claim their CE credit for weekly GameChangers episodes  The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

Donate (no account necessary) | Subscribe (account required) Join Bryan Dean Wright, former CIA Operations Officer, as he dives into today's top stories shaping America and the world. In this episode of The Wright Report, we cover the shocking assassination of Charlie Kirk, Russian drones breaching NATO airspace, Trump's war on Venezuela's cartels, Mexico's tariff fight with China, a pharmaceutical victory in Tennessee, and new revelations in the 9/11 families' lawsuit against Saudi Arabia. From political violence at home to dangerous escalations abroad, today's brief carries heavy news on a day of prayer and remembrance.   Charlie Kirk Assassinated in Utah: The 31-year-old Turning Point USA founder was gunned down while speaking at Utah Valley University. President Trump called him “a martyr for truth and freedom” and ordered flags at half-staff. Video shows a sniper shot to the neck from a rooftop as Kirk addressed thousands of students. MSNBC sparked outrage with coverage that suggested Kirk's “awful words” made his death inevitable. Bryan warns, “The seal has now been broken: if you make those arguments or say those words, you're fair game too.”   Russian Drones Violate Polish Airspace: NATO confirms 19 Russian drones flew over 150 miles into Poland, with several shot down by Dutch and Polish jets. Bryan cautions that even an accident could spark a “Gulf of Tonkin–like incident” dragging NATO into direct war with Moscow.   Trump Escalates War on Venezuela's Cartels: After U.S. forces sank a drug boat killing 11, critics accuse Trump of overstepping presidential authority. War Secretary Pete Hegseth countered: “This strike sent a clear message: If you traffic drugs toward our shores, the United States military will stop you cold.”   Mexico Tariffs Chinese Imports: President Claudia Sheinbaum hikes tariffs on Chinese cars and textiles to 50 percent, aiming to shield Mexican workers and appease Trump's demands to close tariff loopholes. Bryan notes this could undercut Beijing's backdoor into U.S. markets.   Saving U.S. Antibiotics in Tennessee: Trump brokers a deal forcing Walmart and McKesson to buy amoxicillin from Bristol, Tennessee, rescuing America's last antibiotic factory from collapse. “Don't bet against America,” Bryan says, “because with leadership that actually loves this country, we will win.”   9/11 Families' Lawsuit Against Saudi Arabia Advances: A New York judge allows families to pursue claims that Saudi intel officers Omar al-Bayoumi and Fahad al-Thumairy aided hijackers. ProPublica reports al-Bayoumi was a Saudi intel asset in the U.S. coordinating with the GIP. Bryan calls for Trump to declassify CIA files: “It's time for some sunlight on what did or didn't happen that horrific day.”   "And you shall know the truth, and the truth shall make you free." - John 8:32     Take your personal data back with Incogni! Get 60% off an annual plan at incogni.com/TWR and use code TWR at checkout.     Keywords: Charlie Kirk assassination Utah, Trump martyr for truth, MSNBC Charlie Kirk coverage, Russian drones Poland NATO, Trump Venezuela drug cartels strike, Pete Hegseth drug cartels al Qaeda, Mexico tariffs Chinese imports Sheinbaum, Trump tariff war China backdoor, U.S. antibiotics Bristol Tennessee amoxicillin, Walmart McKesson Trump drug deal, 9/11 families lawsuit Saudi Arabia, Omar al-Bayoumi Saudi intel, Fahad al-Thumairy Saudi cleric, CIA Saudi 9/11 declassification

With a career background that has included stops at medical supply and equipment behemoth, McKesson, as well as executive roles at a variety of life sciences companies, Botanical Sciences CEO Gary Long knows healthcare. While his background may not seem like a traditional fit for the medical and hemp-derived cannabis world, his arrival along with other outsiders signal a transformation underway in a category becoming known more for its positive lifestyle impacts than for previous negative stereotypes.In our conversation we talk about what led him to the industry, what he sees as opportunities and threats, and how cannabis has slowly become part of the growing health and wellness movement that continues to unfold across the country.Mentioned in this episode:Botanical SciencesONE59Traktion Talks PodcastSpecial thanks to Go Brewing / Easy Man for being a show sponsor! Use code NATION15 at checkout for either brand to get 15% off your order.We'd love your feedback!

Join hosts Luke Carignan and Bo Brabo for a lively episode of The ASHHRA Podcast, where they chat with Victor Gaines, AVP of Talent Acquisition at Wellstar Health System. Kicking off with NFL banter and a playful scoop on Taylor Swift and Travis Kelce's "engagement" (spoiler: it's all in good fun), the conversation quickly dives into Victor's eclectic career journey—from finance and TV to healthcare, pizza at Papa John's, and bourbon at Sazerac—now circling back to innovative TA in healthcare.Victor shares how his cross-industry experience (spanning high-volume hiring at Comcast and Papa John's to specialized roles at Fiserv and McKesson) equips him to tackle post-pandemic challenges like agility, digital transformation, and operational efficiency. The trio explores the transformative power of AI in TA: from automating scheduling and screening to combating bias and "hallucinations." Thought-provoking questions arise—can AI eradicate human biases, or does it amplify them? How close are we to AI-driven individualized learning or even clinical efficiencies?Key takeaways:Diverse Backgrounds Fuel Innovation: Victor's non-traditional path highlights why healthcare is increasingly recruiting external talent for fresh perspectives.AI's Double-Edged Sword: Essential for high-volume tasks but demands a "human in the loop" to mitigate risks like unintended bias or outdated data.Future-Proofing TA: Insights on pre-boarding, ambient listening in clinics, and ethical AI use—could we see 30%+ efficiency gains in five years?Victor's wisdom: "We've seen unprecedented change; now it's about agility to persevere." Whether you're in HR, TA, or curious about AI's role in work, this episode sparks debate on balancing tech with human judgment.Tune in on your favorite podcast platform or visit ashhra.org/ashhra-podcast. What biases lurk in your processes? Share your thoughts!From Our Sponsors...Optimize Pharmacy Benefits with RxBenefitsElevate your employee benefits while managing costs. Did you know hospital employees fill 25% more prescriptions annually than other industries? Ensure cost-effective, high-quality pharmacy plans by leveraging your hospital's own pharmacies. Discover smarter strategies with RxBenefits.Learn More here - https://rxbene.fit/3ZaurZNStreamline HR Compliance with oneBADGEhealthcareSimplify screening, credentialing, and compliance for healthcare HR. oneBADGEhealthcare from ISB Global offers a tailored solution to keep your workforce compliant and efficient. Built for healthcare leaders, it's your all-in-one compliance tool.Get Started here - https://isbglobalservices.com/onebadgeunitedstates/ashhra/ Support the show

The Future Is Now: APhA President Randy McDonough on Leading Change in Independent PharmacyWhat does the future of independent pharmacy look like—and how do we get there?In this powerful episode of Independent Insights, APhA President and Health Mart pharmacy owner Randy McDonough joins McKesson Health Mart's Chief Pharmacist Nancy Lyons for a candid conversation about the urgent changes needed in pharmacy—and the bold vision that can lead us forward.Randy shares his frontline perspective as both a national leader and a practicing owner.Whether you're a pharmacist, technician, or pharmacy owner, this episode will leave you inspired, informed, and ready to take action. Tune in and be part of the movement to redefine the role—and the value—of independent pharmacy in healthcare.HostSuzanne Feeney, PharmDSenior Director, Pharmacy SolutionsMcKesson/ Health MartGuestsRandy McDonough, PharmD, MS, BCGP, BCPS, FAPhAPresident, American Pharmacists Association (APhA) and Health Mart Pharmacy OwnerNancy Lyons, BSPharm, MBA, CDCESVice President, Chief Pharmacy OfficerMcKesson/ Health MartResourcesHealth Mart Pharmacies can access Health Mart University (HMU) for: Helpful CE courses, advanced trainings, and more Health Mart pharmacists to claim their CE credit for weekly Gamechanger episodes  The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

In today's episode, host Edward Wagoner sits down with Drew DePriest, Director of Real Estate OT at McKesson and recently named one of IFMA's top global influencers in facility management. Drew discusses the importance of mental health for facility management professionals, his own journey with it, and the importance of creating an environment where discussing mental well-being is normalized. The conversation also touches on how technology and AI influence FM as well as answering a few rapid-fire questions from listeners.Sponsor:This episode is sponsored by ODP Business Solutions! Connect with Us:LinkedIn: https://www.linkedin.com/company/ifmaFacebook: https://www.facebook.com/InternationalFacilityManagementAssociation/Twitter: https://twitter.com/IFMAInstagram: https://www.instagram.com/ifma_hq/YouTube: https://youtube.com/ifmaglobalVisit us at https://ifma.org

Welcome to PART ONE of our Three Part series covering the McKesson IdeaShare Conference in Nashville TN.   Today's interviews features: Ashton Maaraba President of IPC Digital Health Independent Pharmacy Cooperative (IPC)   U.S. Representative Buddy Carter Georgia State Congress   Greg Reybold Vice President of Healthcare Policy & General Counsel APCI, Inc.   Christopher Darling Darling Apothecary LLC   Chuck Schneider Lifecykel

As senior vice president of customer distribution experience at McKesson, Ammie McAsey makes it a point to connect her day-to-day work with the company's mission of improving healthcare in every setting. Learn how she's working to connect the healthcare ecosystem to bring additional access and benefits to patients. Highlights include:Her view of the opportunities for collaboration to build a better healthcare value chainDiscussion of how we can improve the patient's experienceAreas where she sees the most potential for innovation across healthcare

What if the key to boosting your pharmacy's revenue—and your community impact—was already within your four walls?In this episode of Independent Insights, host Suzanne Feeney sits down with Alex Anderson, sixth-generation owner of Oswald's Pharmacy, to explore how he transformed a single lift chair into a thriving front-end and DME (Durable Medical Equipment) business that now spans 5,000+ square feet and drives significant revenue.Whether you're a one-person show or managing a full team, this episode is packed with practical, scalable strategies to help you:Start small and smart with DME—even with limited space or staffIdentify top-performing front-end products that meet real community needsUse rentals to generate recurring revenue with minimal investmentLeverage your team's hidden talents to grow marketing and outreachDrive foot traffic with smart merchandising, local partnerships, and online visibilityYou'll also hear how Alex uses inventory as a strategic tool—not just a shelf filler—to create a one-stop shop that keeps customers coming back. If you've ever wondered how to diversify your revenue, better serve your patients, and make your front-end work harder for your business, this is the episode you can't afford to miss.HostSuzanne Feeney, PharmDVP, Pharmacy Retail OperationsMcKesson/Health MartGuestsAlex AndersonOwnerOswald's PharmacyResourcesTune into Independent Insights Episode 12: The Power of Partnerships Health Mart Pharmacies can access Health Mart University (HMU) for:Helpful CE and non-CE courses and more on front-end  Health Mart pharmacists to claim their CE credit for weekly Gamechanger episodes  The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

How do you lead organizational transformation when AI is moving faster than your roadmap can keep up?   Carlie Bissler, a product leader at McKesson, breaks down what it takes to guide large enterprises through change in the age of AI. From building trust and authenticity as a leader to shifting from "change management" to "change leadership," Carlie shares pragmatic advice for preparing your teams — and yourself — for the unknown.   She also gets real about fear in the workplace, the shame some still feel about using AI tools, and why the best CX transformations start on the inside. If you're navigating the messy middle of enterprise innovation, this episode is your blueprint for embracing agility, empowering your people, and staying human in an increasingly automated world. Key Moments:   00:00 Change Leadership, Innovation, and AI04:46 Who is Carlie Bislser of McKesson?06:13 The Role of Psychology in Leadership14:20 Navigating Organizational Transformation18:33 Embracing AI and Building Trust29:12 The Growing Fear of AI in the Workplace34:32 The Shift from AI as a Cost Center to an Asset38:03 Mentorship and Community43:13 Preparing for AI-Driven Transformation45:43 The Human Touch in Customer Experience50:57 Lightning Round: Quick Insights & Advice –Are your teams facing growing demands? Join CX leaders transforming their AI strategy with Agentforce. Start achieving your ambitious goals. Visit salesforce.com/agentforce Mission.org is a media studio producing content alongside world-class clients. Learn more at mission.org

Joe DePinto, MBA, Head of Cell, Gene & Advanced Therapies at McKesson, joins the show to discuss InspiroGene, McKesson's end-to-end platform built to address the complex delivery, coordination, and commercialization needs of cell and gene therapies. He breaks down how InspiroGene integrates logistics, specialty pharmacy, patient support services, and real-time data tracking to close critical gaps in the CGT ecosystem—especially around why many eligible patients are still not being identified, referred, or treated. He also explores the broader vision: enabling scalable access to these therapies as they move from rare diseases to larger populations, and what it will take—from providers, payers, and pharma—to meet that future. Check out Chadi's website for all Healthcare Unfiltered episodes and other content. www.chadinabhan.com/ Watch all Healthcare Unfiltered episodes on YouTube. www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA

In this case, the court considered this issue: Does the Hobbs Act require a federal district court to accept the Federal Communication Commission's legal interpretation of the Telephone Consumer Protection Act?The case was decided on June 20, 2025.The Supreme Court held that the Hobbs Act does not preclude judicial review of an agency's statutory interpretation in district court enforcement proceedings, and district courts must independently determine whether the agency's interpretation is correct under ordinary principles of statutory interpretation. Justice Brett Kavanaugh authored the 6-3 majority opinion of the Court.Courts may grant pre-enforcement review of agency orders through three types of statutes: those that expressly preclude subsequent judicial review in enforcement proceedings (like the Clean Water Act), those that expressly authorize review in both contexts, and those that remain silent on enforcement proceedings (like the Hobbs Act). The Hobbs Act falls into the third category, which triggers a default rule allowing district courts to independently assess agency interpretations. The Administrative Procedure Act codifies this presumption of judicial review, stating that “agency action is subject to judicial review in civil or criminal proceedings for judicial enforcement” unless prior review was adequate and exclusive. The phrase “determine the validity” in the Hobbs Act refers specifically to entering declaratory judgments in pre-enforcement proceedings, not to the broader process of evaluating an agency interpretation's correctness in enforcement actions.The Emergency Price Control Act precedent from Yakus v United States does not control because that wartime statute contained two provisions working together: exclusive jurisdiction language plus an express prohibition against other courts considering validity. Congress chose not to include this second, prohibitive provision when enacting the Hobbs Act six years later, demonstrating its intent not to preclude enforcement-stage review. Practical concerns about potential court disagreements do not override statutory text and administrative law principles, as circuit splits followed by Supreme Court review represent the ordinary judicial process. Requiring all potentially affected parties to challenge every agency order within 60 days or lose their rights would be impractical and unfair, particularly for entities that did not exist when orders issued or had no reason to anticipate future enforcement proceedings.Justice Elena Kagan authored a dissenting opinion, joined by Justices Sonia Sotomayor and Ketanji Brown Jackson, arguing that the Hobbs Act's grant of “exclusive jurisdiction” to appellate courts to “determine the validity” of agency orders plainly precludes district courts from making such determinations in enforcement proceedings.The opinion is presented here in its entirety, but with citations omitted. If you appreciate this episode, please subscribe. Thank you.

Are you tired of inventory headaches draining your time, cash flow, and team morale? In this episode of Independent Insights, we're cracking the code on an often overlooked yet powerful tool in your pharmacy: inventory management.Join host Suzanne Feeney and special guest Britney Woods, Pharmacist in Charge at a Dallas-based McKesson-owned Health Mart, as they reveal how small, strategic changes in inventory can lead to big wins for your pharmacy's bottom line—and your patients' health. You'll discover:How to turn inventory from a back-office burden into a front-line advantage.Real-world strategies to reduce dead stock, avoid costly expirations, and optimize cash flow.The power of team buy-in and how to empower your technicians to take ownership.Why med sync and just-in-time ordering are game changers for both workflow and patient care.Tools and tech that take the guesswork out of inventory—and give you back your time.Whether you're a seasoned pharmacy owner or a technician looking to level up, this episode is packed with actionable insights to help you streamline operations, boost efficiency, and strengthen patient relationships.Don't miss this behind-the-counter look at how smarter inventory can transform your pharmacy from the inside out.HostSuzanne Feeney, PharmDVP, Pharmacy Retail OperationsMcKesson, Health MartGuestsBritney Woods, PharmDPharmacist in Charge Dallas-based McKesson-owned Health Mart ResourcesTune into Episode 11: Maximizing Operations Through Proactive WorkflowHealth Mart Pharmacies can access Health Mart University (HMU) for:  Helpful CE courses and more on inventory management and med syncHealth Mart pharmacists to claim their CE credit for weekly GameChangers episodes   Learn more about McKesson's Pinpoint Community Solutions here: https://my.healthmart.com/purchasing/pinpoint-community-solutions The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

Doug & Dan are getting ready to head to the Big Apple on this week's episode of The Hype! But before they get set for Fanatics Fest 2025, the guys react to the surprising move that sent Red Sox slugger Rafael Devers to the Giants and breifly take a look at his Bowman market. Plus the guys discuss if Shohei's return to the mound be a good or bad thing for his career & collectibility and preview all the events going down at this year's Fanatics Fest in New York. Then Cody talks to Topps sketch card artist Ian McKesson about his recent work in Topps Series 2 Baseball and how it feels to have his work featured in upcoming Disney sets. Plus Ian takes us behind the scenes to show how he chooses what subjects to sketch and gives us a look at some of his exclusive artist proof cards! Watch this episode on our Mojobreak Media YouTube channel! Check out box breaks, interviews and more on our Mojobreak Media YouTube channel and subscribe today. Go to Mojobreak.com to get a spot in breaks of 2025 Topps Chrome Marvel & more! Visit our shop in Santa Clara or order online at mojobreakshop.com

Roberto Moro, de robertomoro.com, y Jorge del Canto, de delcanto.es, repasan los títulos de Solaria, Acciona, Banco Santander o McKesson

Roberto Moro, de robertomoro.com, y Jorge del Canto, de delcanto.es, repasan los títulos de Solaria, Acciona, Banco Santander o McKesson

Whether you're looking for innovative ideas or practical tips, this episode offers valuable insights for a thriving front end. Gain expert insights from Megan Baccam, Director, Product Management at McKesson, and Russell Gong, Co-founder of Cabinet Health. Listeners will discover how independent pharmacies can leverage private-label products to boost patient care and business growth in this episode of Independent Insights. This episode dives into Foster & Thrive, McKesson's over-the-counter private brand. Learn actionable strategies for improving margins, attracting new customers, and enhancing your front-end growth. HostSuzanne Feeney, PharmDVP, Pharmacy Retail OperationsMcKesson, Health MartGuestsVanessa Thompson, PharmDSr. Manager, MarketingMcKesson, Health Mart Megan BaccamDirector, Product ManagementMcKessonRussell GongCo-Founder Cabinet HealthResources Health Mart Pharmacies can learn more about Foster and Thrive at https://www.fosterandthrive.com/ and Front End Insights at my.healthmart.com/purchasing/front-end-insightsEpisode 7: Marketing Mastery: Transform Your Pharmacy with Proven Strategieshttps://podcasts.apple.com/us/podcast/episode-7-marketing-mastery-transform-your-pharmacy/id1753117895?i=1000678415339The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

Sujatha Sivarajah ( @sujatha_sivarajah ) is the Vice President of Strategic Execution & Operational Excellence for McKesson Canada ( @mckessoncanada ).She joins Ara on this week's episode of #TheTamilCreator to discuss the significant impact of her parents while she was growing up, being a part of a graduating class that comprised only 10% females, building teams at multiple companies including LifeLabs and Sanofi, being a woman of colour in a male-dominated field, the importance of building a solid foundation, her fascination with history, and so much more.Follow Sujatha:- LinkedIn (https://www.linkedin.com/in/sujatha-sivarajah-p-eng-80897a9/)   Timestamps00:19 - Ara introduces this week's guest, Sujatha Sivarajah00:43 - Sujatha speaks on her upbringing; Jaffna, Ohio, Nigeria02:19 - Sujatha's dad being her mentor; advice for parents06:08 - Being a woman of colour in a male-dominated field (Electrical Engineering)9:52 - Her time at Ford during a recession in Canada; and then LifeLabs17:11 - Leaving LifeLabs after 7 years to build another team; this time at Sanofi21:10 - What is pharmaceutical manufacturing?22:23 - Was the lack of pharmaceutical manufacturing during the pandemic true?24:17 - What McKesson does, and what her role here is26:13 - What Sujatha hopes to accomplish during her tenure at McKesson27:34 - Her view on work-life balance29:19 - Parkinson's Law - work expands to the time allotted for it30:35 - How she secured her roles; never saying “no”40:24 - What she would have done in another life; anthropology or archaeology42:13 - Advice she would give her 16-year-old self44:02 - The legacy she wants to be remembered for by friends and family45:25 - Creator Confessions53:19 - The Wrap Up Intro MusicProduced And Mixed By:- The Tamil Creator- YanchanWritten By:- Aravinthan Ehamparam- Yanchan Rajmohan     Support the show

In the 5th episode of the “5 Pillars of Wound Care” series, Heather Trumm, Partner Account Manager with VGM & Associates, and Amanda Smithey, Senior Manager, Advocacy and Strategic Partnerships, HME Division with McKesson, explore strategies for building your referral network using your existing referral base and patient population. The episode also covers setting expectations with referral sources and offers tips on keeping them accountable to the rules and regulations you've established. Additionally, Heather and Amanda provide insights into training your referral sources, including conducting in-services, what topics to cover, and how to creatively approach training and education.Tune in to learn how to strengthen your referral network and enhance your wound care program!

Join us for an inspiring episode of the Independent Insights series by McKesson / Health Mart, where we delve into the transformative power of partnerships in the world of independent pharmacies. Hosted by Suzanne Feeney, this episode features insightful conversations with Helen Ianniello and Ellie Geise, two remarkable women who share their journeys and the pivotal role partnerships have played in success.Episode HighlightsIndependent Pharmacies provide personalized care in the communities they serve. This episode dives into how partnerships can enhance services and impact community health and well-being.In this episode you'll hear from Helen Ianniello and Ellie Giese about the power of partnerships within pharmacy. Growing up in a small town in Nebraska, Ellie was inspired by her mother's independent pharmacy. Now a Pharmacy Sales Consultant, she shares her passion for small-town pharmacies and their vital role in community health.Helen's story is one of resilience and determination. From a nurse to a successful pharmacy owner, she discusses the challenges and triumphs of taking over Stockmen's Drug and the essential partnerships that helped her turn the business around.Tune in to hear these compelling stories and gain valuable insights on how partnerships can drive success in independent pharmacies. HostSuzanne Feeney, PharmDVP, Pharmacy Retail OperationsMcKesson, Health MartGuestsHelen Ianniello, RNPharmacy OwnerStockmen's DrugEllie GeisePharmacy Sales ConsultantMcKesson ResourcesHealth Mart Pharmacies can learn more about APhA Project Impact opportunities by reaching out to their McKesson Pharmacy Sales Consultant (PSC) or Vice President, Pharmacy Retail Operations. The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

In the 4th episode of the “5 Pillars of Wound Care” series, Heather Trumm, Partner Account Manager with VGM & Associates, and Amanda Smithey, Senior Manager, Advocacy and Strategic Partnerships, HME Division with McKesson, delve into the essential training for HME staff in wound care. This episode covers what a comprehensive training program would entail for both your referral sources and internal staff. Key topics include disease state training, product category training, and referral and patient engagement training. Gain insights into the importance of clinical training, wound terminology, product category training for your HME staff, and the distinct training needs for sales/marketing teams and resupply staff. ResourceThe Wound Care Manual is exclusively available to VGM members on our members-only portal.

More Top Sustainable Stocks To Consider includes several articles featuring terrific renewable energy, healthcare, branded consumer and natural food stocks. By Ron Robins, MBA Transcript & Links, Episode 152, April 18, 2025 Hello, Ron Robins here. Welcome to my podcast episode 152, published April 18, 2025, titled “More Top Sustainable Stocks To Consider.” It's presented by Investing for the Soul. Investingforthesoul.com is your site for vital global ethical and sustainable investing mentoring, news, commentary, information, and resources. Remember that you can find a full transcript and links to content, including stock symbols and bonus material, on this episode's podcast page at investingforthesoul.com/podcasts. Also, a reminder. I do not evaluate any of the stocks or funds mentioned in these podcasts, and I don't receive any compensation from anyone covered in these podcasts. Furthermore, I will reveal any investments I have in the investments mentioned herein. Additionally, quotes about individual companies are brief. Please visit the podcast's webpage for links to the articles and additional company and stock information. ------------------------------------------------------------- More Top Sustainable Stocks To Consider (1) Now, the following articles offer some interesting investment ideas. The first article is titled ESG Still Matters. 3 Defensive Stocks That Make the Grade. It's by Teresa Rivas and seen on barrons.com. Here are a few quotes from her article. “Portfolio manager Bill Davis is shutting out all the noise and sticking to his guns. The term ESG has been a lightning rod for a long time, but it is—and always has been—simply ‘a proxy for finding a well managed company…' Davis puts his money where his mouth when it comes to the actively managed Hennessy Stance ESG ETF, which doesn't invest in tobacco, fossil fuel, weapons, and similar areas. He does make exceptions based on company principles. The fund uses an algorithm to rank S&P 500 companies by various risk factors and metrics, and identifies those most likely to generate positive alpha and minimize harm. It also helps avoid being reactionary to the zigzags of U.S. policy these days. That strategy, which also avoids large positions, hasn't distinguished itself in these past few years when the Magnificent Seven tech stocks and a handful of other megacaps drove index performance—the fund, though, does have positions in Google, Apple, and Netflix. Still, Davis stands firm. The strategy can show its worth when investors are more concerned with downside risk protection. There are plenty of companies, though, that Davis feels differently about. He likes drug distributor  Cardinal Health CAH —peer to Barron's pick McKesson—because healthcare remains a safe haven and Cardinal has done particularly well—doubling the S&P 500 in recent years. Its earnings growth profile is good and ‘it's a solid company with large enough scale to have pricing power.' Also making the cut is Atmos Energy AIO Davis cites the natural-gas utility's relative momentum—the shares are up nearly 30% in the past year—and its defensive qualities. Although the fund shies away from fossil fuels, distributors like Atmos that are transparent, focused on reducing greenhouse gas emissions, do fit the bill. Davis owns staple General Mills GIS as well, again for its defensive qualities, including a 4% yield, and its size—big enough to exert pricing power. He does see only modest upside, but also ‘low downside, so it's a good fit for our portfolio.'” End quotes. ------------------------------------------------------------- More Top Sustainable Stocks To Consider (2) This second article brings us back to the most likely favourite sector for ethical and sustainable investors. Its title is 5 Renewable Energy Stocks to Buy Amid Growing Market Demand by Nalak Das at Zacks and seen on finance.yahoo.com. Here's some of what Mr. Das says about his picks. “These five renewable stocks have strong long-term potential. These stocks have seen positive earnings estimate revisions in the last 60 days. Each of our picks currently carries a Zacks Rank #2 (Buy). At the same time, these companies pay dividends regularly at an attractive rate. 1. The AES Corp. AES is one of the forerunners in the utility industry's transition to clean energy by investing in sustainable growth and innovative solutions while delivering superior results. AES continues to invest in clean energy projects. In 2024, AES completed the construction of 3 gigawatts (GW) of wind, solar, gas and energy storage. [The company] expects to add a total of 3.2 GW of new renewables to its operating portfolio by the end of 2025… AES has an expected revenue and earnings growth rate of 3.1% and -1.4%, respectively, for the current year… AES has a current dividend yield of 6.32%. The AES Corporation (AES): Free Stock Analysis Report. 2. OGE Energy Corp. OGE has been investing steadily to expand its renewable generation assets. The company is focused on reducing its carbon dioxide emissions to 50-52% by 2030. As of Dec. 31, 2024, OGE owned the 120 megawatts (MW) Centennial, 101 MW OU Spirit and 228 MW Crossroads wind farms. It also owns and operates six solar sites across the state of Oklahoma and one in Arkansas, which comes with a cumulative generation capacity of 32.2 MW… OGE has an expected revenue and earnings growth rate of 0.8% and 3.7%, respectively, for the current year… [The company] has a current dividend yield of 3.88%. OGE Energy Corporation (OGE): Free Stock Analysis Report. 3. WEC Energy Group Inc. WEC is investing in cost-effective zero-carbon generation like solar and wind. During 2025-2029, WEC plans to invest $28 billion, out of which $9.1 billion will be invested in regulated renewable projects. The idea is to further strengthen WEC's renewable portfolio… WEC Energy Group has an expected revenue and earnings growth rate of 9.2% and 8.5%, respectively, for the current year…[It] has a current dividend yield of 3.42%. WEC Energy Group, Inc. (WEC): Free Stock Analysis Report. 4. NiSource Inc. NI expects to invest $19.4 billion during 2025-2029 to modernize infrastructure, which will enhance the reliability of its operations. NISource continues to add clean assets to its portfolio and retire coal-based units. [The company] is set to retire its 100% coal-generating sources between 2026 and 2028 and replace the production volumes with reliable and cleaner options at lower costs. NISource aims to reduce greenhouse gas emissions by 90% by 2030 from the 2005 levels. This initiative can help NISource lower the cost of operations by focusing on new and advanced assets. New products and services can lead to added revenue streams… NiSource has expected revenue and earnings growth rates of 11.1% and 6.9%, respectively, for the current year… [it] has a current dividend yield of 2.94%. NiSource, Inc (NI): Free Stock Analysis Report. 5. CMS Energy Corp. CMS remains one of the primary utility providers in Michigan. CMS plans to invest $20 billion in infrastructure upgrades, repair and clean energy generation during 2025-2029. In November 2024, CMS filed its 20-year renewable energy plan, which includes the addition of nine GW of solar and four GW of wind to its generation portfolio during 2025-2045… CMS Energy has an expected revenue and earnings growth rate of 7.4% and 7.8%, respectively, for the current year… [it] has a current dividend yield of 3.05%. CMS Energy Corporation (CMS): Free Stock Analysis Report.” End quotes. ------------------------------------------------------------- More Top Sustainable Stocks To Consider (3) This third article is an updated version of a February 20, 2025, story. It was featured in my Podcast: The Low-Carbon Stocks for Sustainable Investors. Its new title is Best Natural and Organic Food Stocks to Buy Now in 2025 by Sumit Singh. Again, it's from the great Zacks research group and found on finance.yahoo.com. Here are some quotes from the new article. “Companies like The Hain Celestial Group, Inc. HAIN, General Mills, Inc. GIS and Vital Farms, Inc. VITL are responding to the rising demand for organic, clean-label and ethically sourced foods. With consumers prioritizing transparency, sustainability and minimal processing, the market for natural foods continues to grow. Expanding farm networks, plant-based innovations and a focus on humane, eco-friendly production are shaping the industry's future… The global healthy foods market is expected to reach $2.26 trillion by 2035. 3 Natural Food Stocks to Watch 1. United Natural Foods, Inc. UNFI stands as a prominent player in the natural food sector, serving as one of the largest distributors of organic and natural products in North America. Through its extensive network, United Natural Foods supplies a vast array of products, including fresh produce, pantry staples, dairy alternatives and plant-based foods. With its diverse portfolio, the company caters to both retail giants and independent natural food stores, meeting the growing demand for cleaner, healthier eating options. United Natural Foods has made a strategic shift by realigning its wholesale business into two product-centric divisions — one of which is solely dedicated to natural, organic, specialty and fresh products… This Zacks Rank #2 (Buy) company is increasingly focusing on innovation and sustainability within the natural foods space. The company has committed to enhancing its supply-chain practices, reducing waste and supporting regenerative agriculture initiatives. United Natural Foods is also working closely with suppliers to accelerate food innovation. Upgrades in automation and warehouse processes are leading to better order accuracy, less product waste and faster deliveries. United Natural Foods, Inc. (UNFI): Free Stock Analysis Report. 2. Sprouts Farmers Market, Inc. SFM has been at the forefront of the natural and organic food movement, catering to health-conscious consumers seeking fresh, high-quality and ethically sourced products. The company's commitment to fresh, organic and attribute-driven products sets it apart. This strategic positioning not only resonates with a growing base of wellness-focused consumers but also aligns with broader food industry trends favoring transparency, sustainability and nutritional value… In addition to product innovation, this Zacks Rank #2 company excelled at enhancing customer engagement through strategic merchandising events and effective marketing campaigns. Seasonal events like the Summer Cherry Festival shine a spotlight on fresh, specialty items and educate consumers on better-for-you choices. This approach not only drove strong traffic across its channels but also contributed to its robust e-commerce growth, surpassing $1 billion in sales in 2024. Sprouts Farmers Market, Inc. (SFM): Free Stock Analysis Report. 3. Beyond Meat, Inc. BYND has strategically realigned its product innovation to strengthen its appeal among health-conscious and natural-food-seeking consumers. A standout development in this direction is the launch of Beyond IV and the extended Beyond Steak line. These new offerings have been designed not only to deliver flavor and texture improvements but also to meet heightened consumer expectations around nutrition and ingredient transparency. These products have earned accreditations from respected health organizations, including the American Heart Association, American Diabetes Association and Clean Label Project. This Zacks Rank #2 company has taken a proactive stance, using nutritional credentials and transparent messaging to reposition its products as a better-for-you choice. By doubling down on natural and functional food innovation, the brand is not only aiming to win over skeptical customers but also elevate its products to a new standard that aligns more closely with organic and wellness-oriented trends in the food industry. Beyond Meat, Inc. (BYND): Free Stock Analysis Report. End quotes. ------------------------------------------------------------- Additional article links 1. Title: Analog Devices a Top Socially Responsible Dividend Stock With 2.2% Yield (ADI) on nasdaq.com. By BNK Invest. 2. Title: How to Invest in IonQ (IONQ) on fool.com. By Rachel Warren. 3. Title: 11 Climate-Tech Companies to Watch in 2025 on inc.com. By Chloe Aiello. UK article link Title: Triodos Bank Recognised as Top-Scoring Best Buy by Ethical Consumer on ffnews.com. By Ethical Consumer. ------------------------------------------------------------- Ending Comment These are my top news stories with their stock and fund tips for this podcast, “More Top Sustainable Stocks To Consider.” Please click the like and subscribe buttons wherever you download or listen to this podcast. That helps bring these podcasts to others like you. And please click the share buttons to share this podcast with your friends and family. Let's promote ethical and sustainable investing as a force for hope and prosperity in these troubled times! Contact me if you have any questions. Thank you for listening. I'll talk to you next on May 2nd. Bye for now.   © 2025 Ron Robins, Investing for the Soul

Send us a textThis episode was taped live at the ViVE 2025 conference in Nashville, Tennessee. About This EpisodePatty Hayward, General Manager of Healthcare and Life Sciences at TalkDesk, shares how personalized AI communication in healthcare is becoming reality. In a groundbreaking partnership with Epic, TalkDesk is transforming healthcare contact centers from cost-driven call hubs into vital parts of the care team, integrating support directly into electronic health records and empowering agents to guide patients with empathy and precision. Hayward dives into this evolution and makes a compelling case for co-innovation, challenging outdated metrics and redefining what truly human-centered healthcare can look like. Whether you're a healthcare professional, technology enthusiast, or simply someone who's experienced the frustration of healthcare bureaucracy, this episode offers a compelling vision of how bold thinking and strategic partnerships are creating more human-centered experiences. About Patty HaywardPatty Hayward, General Manager of Healthcare and Life Sciences at Talkdesk, has over a quarter century of industry strategy experience, including at organizations such as McKesson, Medicity, and Humedica. She is an expert in HIE, population health, pharmacy, process redesign for healthcare systems, and increasing access to patient information. Additional ResourcesLinkedIn: @PattyHaywardSupport the show-------- Stay Connected www.leighburgess.com Watch the episodes on YouTube Follow Leigh on Instagram: @theleighaburgess Follow Leigh on LinkedIn: @LeighBurgess Sign up for Leigh's bold newsletter

In the 3rd episode of the “5 Pillars of Wound Care” series, hosts Heather Trumm, Partner Account Manager with VGM & Associates, and Amanda Smithey, Senior Manager, Advocacy and Strategic Partnerships, HME Division with McKesson, dive into the essentials of establishing effective vendor partnerships. They explore strategies for simplifying the process of developing and identifying the right vendor relationships for your business. Heather and Amanda also discuss how to leverage the resources that vendors offer to maximize your success, and how to utilize your relationships to help generate leads together. A lot of these concepts not only work with surgical dressings, but also can apply to HME, DME, respiratory and more. 

Ford v. McKesson

In the second episode of the “5 Pillars of Wound Care” series, Heather Trumm, Partner Account Manager with VGM & Associates, and Amanda Smithey, Senior Manager, Advocacy and Strategic Partnerships, HME Division with McKesson, return to delve into the development of your surgical dressings program. They cover essential components such as the Surgical Dressings LCD, the importance of formulary development, and the order process, including the resupply aspect. This may be the most crucial step of your wound care program development- you won't want to miss this episode!

Join Suzanne Feeney from McKesson Health Mart and guest Josh Borer, a seasoned pharmacy owner, as they explore innovative strategies to enhance pharmacy operations. Discover how synchronizing refills and scheduling patient appointments can revolutionize your pharmacy practice, reduce costs, and improve patient outcomes. Tune in for practical tips and inspiring stories from the frontlines of independent pharmacy. HostSuzanne Feeney, PharmDVP, Pharmacy Retail OperationsMcKesson, Health MartGuestsJosh Borer, PharmDPresident/OwnerRex PharmacyResourcesHealth Mart Pharmacies can access Health Mart University (HMU) for:Helpful CE courses and more on inventory management and med syncHealth Mart pharmacists to claim their CE credit for weekly GameChangers episodes The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

This episode of the Industry Matters Podcast is the first in a five-part series, the Five Pillars of Wound Care: Identify Market Needs. Join industry experts, Heather Trumm, Partner Account Manager with VGM & Associates, and Amanda Smithey, Senior Manager, Advocacy and Strategic Partnerships, HME Division with McKesson, as they discuss how to determine if the wound care market is right for your business, the industry landscape, profitability, and more.  Resources:Wound Care Guide: Determine if the wound care category is right for your businessWound Care Manual: Comprehensive manual on the wound care industry including, an introduction to the industry, product overview, setting up a marketing plan, and additional resourcesVGM Market Data: See who's billing for wound care HCPCS codes or where those referrals are going

Join us for an exciting episode of Independent Insights as Suzanne Feeney sits down with Dr. Elizabeth Skoy from North Dakota State University. They delve into the dynamic transformation of community pharmacists' roles and explore the power of collaborative practice agreements and test-to-treat services. These innovations are opening new doors for pharmacists to make a significant impact in their communities. From empowering pharmacy technicians to embracing a team-based care approach, this episode is brimming with actionable insights and strategies designed to inspire you to lead the charge in pharmacy practice transformation within your state. Whether you're a seasoned pharmacist or just starting your journey, this episode offers valuable guidance on enhancing your pharmacy's influence while keeping patient care at the forefront. Tune in and discover how you can drive positive change and elevate the standard of care in your community pharmacy!HostSuzanne Feeney, PharmDVP, Pharmacy Retail OperationsMcKesson / Health MartGuestElizabeth Skoy, PharmD, FAPhAProfessor and Director of the Center for Collaboration and Advancement in PharmacyNorth Dakota State UniversityResourcesHealth Mart franchise members can access Health Mart University for point-of-care testing, Test-to-Treat, and compliance courses here: Health Mart UniversityThe views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

This week on Geek Off The Street, we're talking about Captain America: Brave New World with our friend Wilbur Mckesson III! We talk about the characters and the action and pacing but also the lackluster story and also why this movie has such huge backlash! All that and so much more on this week's exciting episode of the GOTS Official Podcast!Podcast Timecodes![1:45] What are we drinking this week?[2:30] Fantastic Four Trailer Discussion[14:40] Opening Thoughts and Facts[18:35] Positives[33:35] Negatives[59:30] Rating[1:02:50] What Are We Into This Week?Check Out These Books! When The Sakura Blooms! by J. Leroy Tucker!Wilbur Mckesson's Retribution!Greg Sorber's Mechhaven!Pax Machina Audio Book!Join Us In The Discussion!Email: thegeeksoffthestreet@gmail.comInstagram: @thegotspodSubscribe on Youtube!Like Our Facebook! Twitter: @thegotspodTrent Personal: @trentctuckerMusic: @erictucker__Stuff We Mentioned!Chikara Ramen!Trent Tucker Vlogs!Invincible Season 3!House of Cards!               Dr. Stone!People We Mentioned!Tree of Dreams Music@chikara_ramen@badicalradness@jenjoink@gregerationx@author_wilbur_m@mcpodcast@z_daughter_of_light@mindmattermystery

In this premiere episode, Jessica White, PharmD, VP of Speciality Portfolio & Programs at McKesson, brings over 20 years of experience to the table. From managing oncology's generics portfolio to fostering manufacturer relationships, Jessica shares her unique insights into the strategies that can help navigate drug shortages and ensure continuity in patient care.Tune in as Jessica emphasizes the importance of collaboration among stakeholders to maintain supply chain stability and deliver exceptional care.Check out Jessica's article, Stakeholders Collaborate to Ensure Supply Chain Continuity, where she discusses how effective collaboration can help prevent drug shortages and maintain continuous patient care.

What if scheduling a doctor's appointment was as easy as booking a table at your favorite restaurant? Join for an enlightening discussion with Jeff Gartland, CEO of Relatient, as we unlock the complexities of patient scheduling in healthcare. Jeff shares his unique perspective, drawing from a childhood influenced by behavioral psychologists and a career spanning top healthcare technology firms like McKesson, Ciox, and Elevance. Together, we explore how patient scheduling is much more than a tech challenge; it's about transforming human interactions in healthcare. From understanding the nuances between "new" and "existing" patients to creating a seamless, consumer-centric referral system, Jeff offers invaluable insights into reshaping the way we engage with medical practices.Discover how cutting-edge technology can bridge the gap in appointment scheduling while boosting  patient access and satisfaction. Jeff explains the paradox of how long waits for appointments can coexist with underutilized clinical time, offering solutions that hinge on sophisticated scheduling systems and automated waitlists. We discuss the significance of a portal-free experience that simplifies the referral process and enhances convenience for patients. Whether it's aligning scheduling rules to meet patient demand or ensuring operational precision without sacrificing accessibility, this episode provides a roadmap to boost patient engagement for a better healthcare experience.Host David E. Williams is president of healthcare strategy consulting firm Health Business Group. Produced by Dafna Williams.

Administrative Law: Does the Hobbs Act require district courts to accept the FCC's legal interpretation of the Telephone Consumer Protection Act? - Argued: Tue, 21 Jan 2025 14:35:35 EDT

McLaughlin Chiropractic Assoc. v. McKesson Corp. | 01/21/25 | Docket #: 23-1226

Judge Aileen Cannon is popping off, the Alex Jones bankruptcy continues to be crazy, and judges in Arkansas are going to war with each other. Plus, as always, we'll check in with our pal Rudy.   Links: Alex Jones - TX Plaintiffs settlement https://storage.courtlistener.com/recap/gov.uscourts.txsb.459750/gov.uscourts.txsb.459750.1011.0.pdf   McKesson v. Arkansas complaint https://www.documentcloud.org/documents/3671323-McKesson-Complaint/   Baker Jan. 1 appointment orders https://arkansasadvocate.com/wp-content/uploads/2025/01/Appointment-Orders.pdf   Arkansas Administrative Order 24 https://opinions.arcourts.gov/ark/supremecourt/en/item/523224/index.do   Arkansas Supreme Court per curiam opinion 1/6/25 https://opinions.arcourts.gov/ark/supremecourt/en/item/523226/index.do   “Order of Chief Justice,” 2025 Ark. 4 https://opinions.arcourts.gov/ark/supremecourt/en/item/523231/index.do   Trump emergency motion to block release of Smith Report https://storage.courtlistener.com/recap/gov.uscourts.flsd.648652/gov.uscourts.flsd.648652.700.0_1.pdf   Giuliani NY docket https://storage.courtlistener.com/recap/gov.uscourts.nysd.627518/ Show Links: https://www.lawandchaospod.com/ BlueSky: @LawAndChaosPod Threads: @LawAndChaosPod Twitter: @LawAndChaosPod Patreon: patreon.com/LawAndChaosPod  

In this episode of Money Tales, our guest is Sara Eversden. Sara grew up in a neighborhood where labels like 'the lower-income side of town' were casually tossed around. But for her, it wasn't about what her family didn't have, it was about what they gained. In a community rich with diversity, both socioeconomically and racially, Sara developed a deep comfort and appreciation for being in all kinds of environments. That early exposure shaped how she navigates the world today, including her relationship with money and identity. Sara Eversden is a leader in healthcare finance, and operations with over two decades of experience driving success for physician organizations and medical groups across the U.S. As a Certified Public Accountant (CPA) with a master's in healthcare administration, Sara has a proven track record of optimizing organizational performance, transforming complex organizations, and leading high-performing teams. Currently serving as Senior Vice President of Women & Children's Operations at Envision Healthcare, Sara manages a multi-state portfolio spanning 15 states, 70 hospitals, and 500+ clinicians. Previously, Sara held pivotal roles such as Market President & CEO at Women's Health USA, where she integrated multiple practices post-acquisition, and as a CFO within McKesson's US Oncology Network, where she spearheaded financial strategies for Network practices. Sara's expertise spans startups, turnarounds, post-merger integrations, and complex reorganizations, making her uniquely positioned to navigate challenging healthcare environments. Beyond her professional accomplishments, Sara is passionate about empowering the next generation of leaders through education and service. She is a former board member at the National Charity League and co-founded a nonprofit aimed at providing college scholarships to high school graduates from underserved populations. A four-time participant in the Phoenix Rock ‘n' Roll Half Marathon, Sara is also an avid adventurer, having completed the Grand Canyon Rim-to-Rim trek three times.

In this episode, Scott Becker discusses five stocks that faced significant declines, including Tempus AI, Coinbase, Tesla, McKesson, and Zimmer Biomet, each reflecting key trends in healthcare, AI, and the broader market. He also shares gratitude for the podcast's top ranking on Apple Business News.

NFL owners approved private equity firms investing in teams this season, we talk about the soaring franchise valuations and hear a player's perspective on money. (00:21) Emily Flippen and Matt Argersinger discuss: - Weak jobs data, inverted yield curve, and whether the market will cheer a larger rate cut this fall. - Why private equity is interested in Smartsheet and putting money into NFL franchises this season. - The latest earnings updates from: Toro, Docusign, and ABM Industries (19:11) Brandon Copeland played ten years in the NFL – now the linebacker is an ivy league professor, author, and advocate for college athletes. Copeland talks through his book Your Money Playbook, the realities of an NFL contract, and how some college players are finally getting their due. (34:45) Emily and Matt break down two stocks on their radar: McKesson and AO Smith. Stocks discussed: SMAR, DOCU, TTC, ABM, MCK, AOS Host: Dylan Lewis Guests: Emily Flippen, Matt Argersinger Engineers: Dan Boyd Learn more about your ad choices. Visit megaphone.fm/adchoices